[Retracted] A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis

Table 1

Basic clinical features of 15 literature were included in our study.

Study	Age	Gender	Follow-up time (month)	The experimental group ()	Control group ()	NOS score	HAMD score
Liu 2017		Female	3 ~ 12	52/66	15/31	8
Chen 2018		Female	12~24	178/262	112/386	7
Simmons 2016		Female	6 ~ 12	118/142	98/217	8
Xiang 2017		Female	6 ~24	78/133	21/43	7
Rosen 2005		Female	6 ~24	156/296	140/296	8
Zhu 2021		Female	4 ~ 12	93/179	86/179	7
Cho 2019		Female	6 ~ 12	50/81	31/81	9
Yu 2020		Female	6 ~ 18	67/102	35/102	9
Xu 2021		Female	6 ~24	45/75	30/75	7
Freydanck 2012		Female	4 ~24	32/56	24/56	8
Chen 2015		Female	3 ~ 12	178/323	145/323	7
Chen 2017		Female	4 ~ 14	98/178	80/178	7
Gao 2021		Female	6 ~24	40/65	25/65	9
Huang 2015		Female	6 ~24	48/78	30/78	8
Tang 2021		Female	4 ~ 12	112/190	78/190	9